Pharmaceutical Headlines for 27 may 2011 ( Friday )

• Rigel Pharmaceuticals, Inc. (RIGL) Gets $130 Million, Will Pick Up Where Pfizer Inc. (PFE) Left Off More...



• Solazyme, Inc. IPO Nets up to $227 Million More...

• Pharmascience Inc. Acquires Aegera Therapeutics; Aegera's Employees to Retain Their Jobs More...

• Nkunzi Pharmaceuticals Buys Merck SA's Pharmaceuticals Operations More...

• Cerecor Acquires FP01 From Fells Laboratories More...

• Medicago, Inc. Announces Research Collaboration for the Development of a VLP Vaccine Candidate for the Prevention of Ebola With the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) More... 

• Roche (RHHBY) and TeaRx Ltd. Sign License Agreement for Innovative Drugs Fighting Thrombosis, Stroke, and Embolism More...

 

• Affymetrix (Santa Clara, California) (AFFX) Selects BioDiscovery, Inc. as OncoScan(TM) FFPE Express Preferred Software Provider More...

• Dr. Joseph Sinkule Named as President and Chief Operating Officer of Compass Biotechnologies, Inc. More...

• Nuvo Research Inc. (NRI.TO) Announces 2011 First Quarter Results More...

• InSite Vision (ISV) Announces Joint Patent Infringement Lawsuit with Merck & Co., Inc. (MRK) Against Sandoz, Inc. More...

 

• IntelliPharmaCeutics Provides Update on Activities Related to Generic Seroquel XR( More... 

• American Scientific Resources Inc. (ASRO.PK) Announces Dismissal of Sanomedics International Holdings Inc.. Lawsuit More...

• New England Biolabs, Inc. Opens New Subsidiary Office in France More...

• 4SC AG (VSC.DU)'s $1.4 Billion Promise Hinges on Study More...

• Avastin Likely Will be Approved for Ovarian Cancer, Roche Holding AG (RHHBF.PK) Says More... 

• Alnylam Pharmaceuticals (ALNY) Looks to Shine at American Society of Clinical Oncology, Plans for a RNAi Resurgence More... 

• UCB Group (UCBJF.PK) Release: New Data for Cimzia® (Certolizumab Pegol) Showed a Rapid Clinical Response Across a Broad Population of Rheumatoid Arthritis (RA) Patients More... 

• Neurologix, Inc. Presents One-Year Follow-Up Data From Phase 2 Study of NLX-P101 in Parkinson's Disease at International Neuromodulation Society 10th World Congress More...

• Labeling and Script Use May Cause Problems For Optimer Pharmaceuticals, Inc. (OPTR)'s New Drug More...

• MAP Pharmaceuticals, Inc. (MAPP) Submits New Drug Application to FDA for LEVADEX® Orally Inhaled Migraine Drug More...

• Skin Cells 'Turned into Neurons' by US Scientists, Study in Nature More... 

• Human Brain's 'Bat Sight' Found, Study in PLoS ONE More... 

• Drug to Reduce Stress Hormone Levels May Limit Impact of Bad Memories: University of Montreal Study More... 

• Is a Repeat Flu Shot Needed? This Fall, Maybe Not More... 

• New Prostate Cancer Treatments Today: Zytiga And The Yunzi Mushroom? National Institutes of Health (NIH), The New England Journal of Medicine Findings More...

• VertiFlex Nabs Another $14 Million In Venture Money for Spine Device More...

• FDA Needs More Data From Cardica, Inc. (CRDC) More... 

• EMIT Corporation Receives FDA 510(k) Clearance for HypothermX Blood and Fluid Warmer More... 

• Roche (RHHBY) Signs Exclusive Agreement with IT-IS Life Sciences Ltd on the New LightCycler(R) Nano Instrument More... 

• David A. Battat Named Atrion (ATRI) CEO More...

( Source: Biospace.com )
Tags: ,

About author

Make it happen !!

0 comments

Leave a Reply

Related Posts Plugin for WordPress, Blogger...